UBS Group
ABEV icon

UBS Group’s Ambev ABEV Stock Holding History

UBS Group’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,200
Closed -$7K – 8443
2015
Q1 		$7K Hold
1,200
– – ﹤0.01% 7883
2014
Q4 		$7K Buy
+1,200
New +$7.58K ﹤0.01% 8684

Other funds holding ABEV

First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
RWC Asset Management
RWC Asset Management London, United Kingdom $2.7B AUM 20.82% 1-Year Est. Return
Private Management Group
Private Management Group Irvine, California $3.63B AUM 11.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Formuepleje A/S
Formuepleje A/S Aarhus C, Denmark $1.21B AUM 21.62% 1-Year Est. Return

UBS Group's ABEV Position: Q3 2026 in Review

UBS Group increased its Ambev (ABEV) stake by 27% in Q3 2026, buying an estimated $4.95M and bringing the position to 7,903,356 shares worth $23.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2515.

UBS Group first reported a position in ABEV in Q4 2014 and has held it in 48 quarters since. The position peaked at $33.7M in Q1 2025. 269 funds tracked by Wall St. Rank hold ABEV as of Q3 2026.

  • UBS Group held 7,903,356 shares of Ambev worth $23.1M as of Q3 2026.
  • UBS Group bought 1,659,406 Ambev shares in Q3 2026, an estimated $4.95M.
  • Ambev made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #2515 holding.
  • UBS Group first reported a position in Ambev in Q4 2014 and has held it in 48 quarters since.
  • UBS Group's Ambev position peaked at $33.7M in Q1 2025.
  • 269 funds tracked by Wall St. Rank held Ambev as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.